Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Pradofloxacin

A third-generation veterinary fluoroquinolone, discovered in 1994 and authorised in the European Union in 2011 for bacterial infections in dogs and cats. This family brings together the active ingredient.

Did you know?Born for companion animals, in 2024 it was also authorised in the United States for respiratory diseases of cattle and pigs.

PradofloxacinGo to the active ingredient →
PradofloxacinActive ingredientPradofloxacinCat. No. P-P160-001CAS 195532-12-8

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.